Home/Filings/4/0001209191-17-007110
4//SEC Filing

Conatus Pharmaceuticals Inc. 4

Accession 0001209191-17-007110

CIK 0001383701operating

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:29 PM ET

Size

5.8 KB

Accession

0001209191-17-007110

Insider Transaction Report

Form 4
Period: 2017-01-26
RIPLEY DANIEL L.
SVP, Bus Dev, P&A Mgmt
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-01-26+73,00073,000 total
    Exercise: $4.21Exp: 2027-01-25Common Stock (73,000 underlying)
Footnotes (1)
  • [F1]The option was granted on January 26, 2017. 25% of the total number of shares of common stock subject to the option will vest on January 26, 2018, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Issuer

Conatus Pharmaceuticals Inc.

CIK 0001383701

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001383701

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:29 PM ET
Size
5.8 KB